I questioned the National Health and Medical Research Council (NHMRC) on why taxpayers are funding a new $5 million vaccine-adjuvant research centre when Australians still haven’t been given clear answers about the safety of existing adjuvants.

Their written response to my questions confirmed the project was funded simply because peer reviewers ranked it highly, saying that “there are only seven adjuvants used in license vaccines which limits the choice” and the NHMRC’s Centres of Research Excellence aims to “discover novel adjuvants to improve vaccine development.”

That’s not oversight – that’s the NHMRC waving through millions without addressing the real issues.

I asked directly whether concerns about aluminum-based adjuvants or neurological conditions played any role and they couldn’t give me an answer.

I also confirmed that any new vaccine technology developed with Australian taxpayer money WILL NOT be owned by Australians.

This is simply not good enough.

Taxpayers should not be funding research that lines the pockets of big pharmaceutical companies. Any intellectual property generated through these grants must belong to the taxpayers. Handing over valuable IP to entities to monetise at our expense provides zero return to the taxpayers.

This has to stop!

For a billion-dollar grant body, Australians deserve better than vague justifications and no clear outcomes.

Australians deserve accountability that matches the scale of the spending.

— February | Senate Estimates

Transcript

Senator ROBERTS: Could I turn to the National Health and Medical Research Council, please. In 2025, the National Health and Medical Research Council funded the Vaccine Adjuvant Discovery and Development Centre of Research Excellence—CRE—led by Professor Katherine Andrews at Griffith University, with $5 million as part of a $72 million CRE package. This grant focuses on discovering new adjuvants to enhance vaccine efficacy, safety and related purposes. First question: Why do we need new adjuvants? What’s wrong with the existing adjuvants?  

Prof. Wesselingh: We assess grants through a peer review process. Through that process, we utilise experts from around Australia to assess all of the grants that come to us—whether it’s for a centre of research excellence, an investigator grant or an ideas grant. The way that CRE would’ve been assessed would’ve been through that peer review process. Through that peer review process, they would’ve been elevated to the top of that scheme and would’ve been funded on the basis of their peers indicating that this was high-quality research that was likely to have a significant impact on health in Australia. We would take that on board; therefore, if they were ranked accordingly, we would fund them.  

Senator ROBERTS: So you don’t know the reasons why their peers elevated it to No. 1?  

Prof. Wesselingh: I would have to go back and look at all of the assessments by those peers. Obviously, I don’t have that directly in front of me at the moment.  

Senator ROBERTS: Could you do that on notice, please? We’d like to know why that research was approved, why we need new adjuvants, and what’s wrong with the existing adjuvants? 

Prof. Wesselingh: I’m very happy to look back at the peer review. But what I can guarantee you is that they would have been regarded as excellent research likely to produce significant impact.  

Senator ROBERTS: I’d like to know what they are.  

Prof. Wesselingh: Sure.  

Senator ROBERTS: Thank you. Adjuvants and vaccines are there to enhance the body’s immune response to the antigen. Common adjuvants include aluminium hydroxide, aluminium phosphate, amorphous aluminium hydroxyphosphate sulphate and potassium aluminium sulphate. These have been widely linked to neurological conditions spontaneously occurring after vaccination. Is this program an admission that there might be a level of truth to the link between aluminium in vaccines and autism? I guess you wouldn’t know, because you don’t know the—  

Prof. Wesselingh: So you’re asking us if the fact that we funded the CRE is an admission? We, again, funded the CRE on the basis of the scores that the CRE obtained. Those scores would indicate the quality of the science and the likelihood of obtaining high-quality evidence to improve the health of Australians.  

Senator ROBERTS: Right, and you’re going to find the reason anyway, so perhaps you could check if there is any aspect of truth to the link between aluminium in vaccines and autism as part of the reasons for developing a new adjuvant?  

Prof. Wesselingh: We can certainly look at the arguments that the CRE made and the peer review of that CRE.  

Senator ROBERTS: Thank you. If research is successful and you find an effective adjuvant that is not neurotoxic, who will own the intellectual property the taxpayers just funded?  

Prof. Wesselingh: The way our granting system works is that the intellectual property developed by—the people who get the grants from us, which are normally medical research institutes or universities or members of those organisations, own the intellectual property. So the intellectual property would be assigned according to a university’s intellectual property rules or a medical research institute’s rules. I’m not sure, with that CRE, where they were.  

Senator ROBERTS: A $5 million synergy grant was awarded in 2024 to a multi-institutional team, including Monash University, to optimise vaccines for respiratory viruses, like influenza and RSV. This includes evaluating safety profiles to improve protection while minimising risks. If that develops new technology which achieves that objective, who will own that IP?  

Prof. Wesselingh: Again, the IP would be organised according to the rules developed by the organisations as part of that synergy grant. Synergy grants tend to have a number of organisations from around Australia, so I imagine there are multiple universities and MRIs involved in that synergy grant, and they will have developed an IP policy and the IP will be owned according to that policy.  

Senator ROBERTS: But not by the Australian government?  

Prof. Wesselingh: Not by NHMRC or by the government.  

Senator ROBERTS: We’re very concerned about the level of spending in this government. Professor Bette Liu from the National Centre for Immunisation Research and Surveillance received a $2.79 million investigator grant in 2024 to study adult vaccination programs. This explicitly includes assessing vaccine safety, identifying risks in high-risk groups and informing safer program designs. What was the outcome of that grant?  

Prof. Wesselingh: Again, if I knew the outcomes of all of the grants that I fund—we fund a billion dollars worth of grants every year—I think I’d be pretty good. I can’t tell you the outcome of that grant, but we can take that on notice.  

Senator ROBERTS: But you still think you’re pretty good?  

Prof. Wesselingh: Do I think I’m personally pretty good or the NHMRC is very good?  

Senator ROBERTS: Both! Okay, thank you very much. 

I welcomed the ACCC’s decision to oppose the takeover of the insurance arm of the Royal Automobile Club of Western Australia by the IAG Group – and pushed hard on a bigger issue: the revolving door between regulators and major law firms.

I raised recent examples of senior ACCC figures moving straight into firms with competition clients, stressing that, even with separation deeds, the perception and potential for insider advantage remain.

Australians deserve a regulator beyond reproach, and senior officials shouldn’t be able to jump straight into the industries they once oversaw.

It’s time to restore integrity and end the cosy pipeline.

— February | Senate Estimates

Transcript

CHAIR: Senator Roberts.  

Senator ROBERTS: Thank you for appearing again.  

Ms Cass-Gottlieb: It’s a pleasure.  

Senator ROBERTS: It was intriguing hearing some of your comments in answer to Senator Sharma—taking on Apple and mentioning Apple Pay and some of your other comments. I just use cash, because governments have been trying to get rid of cash, so we have to protect it. Anyway, it was very brave, so thank you for your refreshing comments. I’m going to start with a compliment, actually. In October, we discussed the growing concentration in the ownership of insurance companies. You mentioned you were reviewing the takeover of the insurance arm of the Royal Automobile Club of Western Australia by the IAG Group. I note that, on 11 December, the ACCC announced the takeover had been opposed on the basis of a reduction in competition. Thank you. That’s all I wanted to say on that. I hope this is the start of the end of market concentration in insurance.  

Ms Cass-Gottlieb: It was based upon a careful analysis of the market conditions in Western Australia. It is possible that transaction will be brought back to us under the mandatory merger notification regime. The parties did foreshadow that when we announced the opposition under the informal regime. So it may be reassessed.  

Senator ROBERTS: Tonight’s line of questioning is about a potential revolving door of staff between the ACCC and private legal firms. Are there restrictions on someone who is on the ACCC payroll, especially the executive, leaving and immediately taking a position in the business they may have just been regulating at ACCC.  

Ms Cass-Gottlieb: We require the entry into a separation deed that—  

Senator ROBERTS: What does that mean?  

Ms Cass-Gottlieb: They enter into an agreement with the ACCC, which is a binding, enforceable agreement, to firstly preserve the confidentiality of the information that has been received and also to continue to observe obligations that applied under the employment in relation to conflict of interest. We did, in one case, specify a period of required leave before employment could be taken up in a private law firm, but we look at that question—beyond the general obligations in relation to conflict of interest and preservation of confidential information—on a case-by-case basis.  

Senator ROBERTS: Is signing that deed a requirement that the prospective employee must agree to before signing up?  

Ms Cass-Gottlieb: Yes. Employees are obliged to do so, and commissioners enter into a code which, during the term, obliges us to comply with all statutory obligations and legal obligations and also to enter into that separation agreement upon leaving.  

Senator ROBERTS: That relies on trust. It would be very difficult to enforce it, because you don’t know what’s happening in the new employer’s offices.  

Ms Cass-Gottlieb: We have some observation because we see who comes before us. But, yes, we do not know what is being said.  

Senator ROBERTS: The Australian Financial Review has reported on this topic, and I’m considering legislation to stop politicians and senior bureaucrats leaving and going to work for a company they were just regulating. This practice is too commonplace. ACCC Commissioner Liza Carver—is that how you pronounce her name?  

Ms Cass-Gottlieb: Yes.  

Senator ROBERTS: She left in May 2025, halfway through her term, and went to work for Herbert Smith Freehills. Is that correct?  

Ms Cass-Gottlieb: It is correct.  

Senator ROBERTS: Did you address this move at the time, in respect of the perception—and I’m sure this was a false perception—that HSF bought off an effective commissioner with a large job offer?  

Ms Cass-Gottlieb: I think that is an incorrect perception, and Ms Carver did sign a separation agreement.  

Senator ROBERTS: Commissioner Carver was the enforcement committee chair for the 2023-24 ACCC prosecution of BINGO bins. BINGO bins were represented by Herbert Smith Freehills. Bingo lost and were fined $30 million. In the Sigma Healthcare and Chemist Warehouse merger—  

Ms Cass-Gottlieb: Sorry; just one moment. I should note that, to my knowledge, though it was resolved before I became chair, Ms McDonald would know Miss Carver was conflicted and did not participate in the consideration of BINGO matters when she came to the ACCC. 

Senator ROBERTS: Okay, thank you. In the Sigma Healthcare—Chemist Warehouse merger, Carver as deputy chair of the Mergers Review Committee participated in merger assessments in that period. The merger was approved in November 2024. Herbert Smith Freehills advised Chemist Warehouse—I’m not suggesting misconduct in any way by any party, but I am saying the capacity for corruption exists in these arrangements. I think you’re acknowledging that.  

Ms Cass-Gottlieb: We have a very clear and very strict conflict policy. Commissioners are required to disclose conflicts of all work that has been done, if they have been in private practice when they join the ACCC, that results, depending upon the extent of the seniority. If it’s a one-off transaction, it’s at one end of the spectrum; if it’s continued advising, it’s at another. If at the continued-advising level, that person will be conflicted and not have involvement in matters for that company for a number of years while at the ACCC. But, if a clear disclosure is given, the chair receives advice on it from our general counsel and our CEO, and I then take a recommendation to the commission, and we decide and record in a register the treatment of that conflict. So we take that very seriously. Frequently, for the initial period, when commissioners join, if they have been in private practice, they will be absented from a number of matters. They leave meetings, they don’t participate at all in the deliberations, they don’t receive papers, and they do not then participate in decision-making.  

Senator ROBERTS: Of course, I didn’t think of that, but there are potential conflicts entering ACCC as well as departing from ACCC.  

Ms Cass-Gottlieb: There are. There is an objective to bring in highly skilled and experienced people. We have many highly skilled and experienced people who have worked in the public service throughout their career, and they are significant—they are the majority of contributors in the ACCC, there is no doubt—but we also bring in and are keen to attract appropriate people with skill levels, and that requires careful management.  

Senator ROBERTS: I suppose it’s small, but there may be some people who want to get into ACCC so they can get out again later and use their contacts. It’s always a possibility.  

Ms Cass-Gottlieb: It’s a possibility. We do seek through our legal arrangements in the separation deed to manage this, but it’s a possibility.  

Senator ROBERTS: Jennifer Barron was promoted to general counsel for merger reform in early 2025—this is my last question—with a major task on the books: preparation for merger law changes. In late April 2025, King & Wood Mallesons announced her appointment as a partner in their national competition team in Sydney, a team which does merger cases. The law says this person can’t use direct knowledge of an upcoming event at the new company, but they can use any other insider information to make themselves a valuable new employee. Is there anything being done about that?  

Ms Cass-Gottlieb: Ms Barron also entered into an agreement undertaking ongoing obligations to preserve confidential information.  

Senator ROBERTS: Thank you very much.  

Ms Cass-Gottlieb: My pleasure.

We know that no new laws would’ve stopped the Bondi atrocity. The real issue is why ASIO, the AFP and NSW Police didn’t act on the warnings they already had.

I asked the Official Secretary, Ms Anne Sheehan, of the Royal Commission on Antisemitism and Social Cohesion how a terrorist on an ASIO watchlist was still able to get a firearms licence, what surveillance was actually happening, and why critical intelligence wasn’t shared.

The commission confirmed these failures will be scrutinized – including whether agencies simply didn’t do their job.

Australians deserve a Royal Commission that delivers real answers and a safer future for everyone.

Transcript

CHAIR: Senator Roberts?  

Senator ROBERTS: The commission found that no further legislative measures would have prevented the Bondi atrocity, but what could have been done by either ASIO, AFP or New South Wales police that could have prevented this atrocity?  

Ms Sheehan: In relation to the interim report, I’d note that we commenced our second hearing block today, which is expected to run for up to three weeks. The interim report identified that there are a number of issues that needed to be further examined during this next hearing block, and that’s what we’re doing at the moment. Other than what recommendations that the commission has made that are in the interim report itself, we need to wait and see what comes out of this hearing block.  

Senator ROBERTS: I can understand that. When will we find out? Is it in the next interim report?  

Ms Sheehan: If the commissioner determines that another report is required before the final report—there’s a final report that’s due by 14 December—it’s open to the commissioner to issue other recommendations or another report along the way if she considers it appropriate to do so. It’s too early to say whether it would be needed to do that, but it’s something that can be done.  

Senator ROBERTS: I can understand your sensitivity about this, and I can understand that a lot of people will be anxious to find out why ASIO, the AFP and the New South Wales police didn’t take action. Will the commission consider how one of the terrorists got a clearance to purchase a firearm when the person had been on a watchlist with ASIO?  

Ms Sheehan: In this hearing block, the commission is considering term of reference C, which goes to the circumstances in the lead-up to the Bondi attack. There will be a range of issues considered in that hearing block, some of which will be in public, and some will have to be held in closed session, either to avoid prejudicing the criminal trial or because it’s dealing with classified information.  

Senator ROBERTS: This may be another sensitive question. Were ASIO or the AFP aware that a firearms licence had been issued to one of the terrorists by the New South Wales weapons licensing branch?  

Ms Sheehan: That really goes to the substance of matters that the commission might be looking at. I couldn’t answer that.  

Senator ROBERTS: Will the commission consider what level of surveillance was directed to the murdering terrorists when they were already on ASIO’s radar?  

Ms Sheehan: Broadly, the factors that the commission is considering during this hearing block go to the terrorism threat level, the security environment in the lead-up to the attack, and the conduct of security, intelligence and law enforcement agencies relevant to the attack. I think that goes to the issue that you’ve just raised. It will also look at the security arrangements for the Chanukah by the Sea event, and how intelligence about individuals known to authorities is utilised and shared between agencies to then inform decisions made by security, intelligence and law enforcement agencies, including, for example, how individuals are monitored and how decisions in respect of firearms licence applications are made. Yes, those things will be looked at.  

Senator ROBERTS: The commission will consider if any agency did not perform their duties to protect Australians. That’s clear.  

Ms Sheehan: The commission will be looking at the conduct of intelligence and law enforcement agencies in relation to those issues I’ve outlined.  

Senator ROBERTS: Are you familiar with the letter from the royal commission to Gab, in the United States?  

Ms Sheehan: I don’t think so, no.  

Senator ROBERTS: The commission sent the social media company Gab, in the United States, a letter. From what the owner of Gab posted on social media, it’s not possible to get a clear idea of what your intent was. Can you please explain what that letter was all about? Do you want me to read the letter?  

Ms Sheehan: I don’t have that letter, so I think I would have to take it on notice.  

Senator ROBERTS: Thank you. Your letter included a statement that failure to comply with the notice carried a criminal penalty of 12 months in prison. Is it accurate to threaten a US citizen in the United States with a criminal prosecution under Australian law?  

Ms Sheehan: I don’t have that correspondence. I think it’s best if I take that on notice.  

Senator ROBERTS: Gab have used the United States first amendment as a defence to such actions in the past, including from our eSafety Commissioner. Could you tell me, on notice, why you’d take the action when you know the US constitution precludes you from taking that action.  

Ms Sheehan: I’ll take that on notice as well—once I’ve seen the correspondence.  

Senator ROBERTS: Thank you.  

CHAIR: Thank you, Senator Roberts, for your efficiency in asking those questions. 

At the February Senate Estimates, I raised concerns that the Australian Flag was absent from The Australia Day Council’s website.

I am pleased to see that it has now been restored.

Our flag is a symbol of our shared values, our democracy and our monocultural society.

Displaying it proudly reminds us of all that we can be united under one flag.

Transcript

CHAIR: We will head straight to questions.  

Senator ROBERTS: Thank you for being here tonight. Senator Ayres, you had better be ready for a long session.  

Senator Ayres: I’m all ears.  

Senator ROBERTS: At the last estimates, I asked you why the Australia Day Council did not have an Australian flag on their website. I’m pleased to see that you now have an Australian flag. Thank you. Well done. It’s good to see.  

Mr Ashurst: I would like to say thank you, Senator. As the interim CEO, once that was brought to my attention, as a former soldier myself, I found that was very important to rectify.  

Senator ROBERTS: That is gratifying to hear. Thank you. I note that you have removed the flash screen acknowledgement of country and instead displayed the Aboriginal flag in your header, which is a fair compromise that I hope leads to further engagement with Australia Day by the Aboriginal community.  

Mr Ashurst: Yes, Senator. It was a deliberate choice in accordance with normal government convention to display not only the Australian national flag but also the Aboriginal and Torres Strait Islander flag. We obviously are aiming for Australia Day and the Australian of the Year awards to be inclusive as much as possible and be representative of our entire nation and the make-up of our entire nation.  

Senator ROBERTS: Thank you. That’s all.